Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide
Nanoscale Advances · 2026 · 8 (15) · 4347-4361
DOI: 10.1039/d5na01168j ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale Advances, 2026. Verfasst von Batoul Makiabadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Sirjan University of Technology Sirjan Iran. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The interaction of cyclic peptides with pyrazinamide holds promise for their use as stable and biocompatible carriers for controlled drug delivery in the treatment of tuberculosis.
Autor:innen und Institutionen
- Department of Chemical Engineering, Sirjan University of Technology Sirjan Iran.
- Department of Chemistry, ShQ.C., Islamic Azad University Shahr-e Qods Iran fnaderi@iau.ac.ir.
- Department of Chemistry, Payame Noor University (pnu) P. O. Box 19395-4697 Tehran Iran.
- Faculty of Medicine, University of Debrecen 4032 Debrecen Hungary.
ORCID-Profile: Fereshteh Naderi
Zitieren
APA
Makiabadi, B., Naderi, F., Zakarianezhad, M., & Raessi, A. (2026). Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide. Nanoscale Advances, 8(15), 4347-4361. https://doi.org/10.1039/d5na01168j
Vancouver
Makiabadi B, Naderi F, Zakarianezhad M, Raessi A. Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide. Nanoscale Advances. 2026;8(15):4347-4361. doi:10.1039/d5na01168j
BibTeX
@article{Makiabadi2026,
author = {Makiabadi, Batoul and Naderi, Fereshteh and Zakarianezhad, Mohammad and Raessi, Aria},
title = {Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide},
journal = {Nanoscale Advances},
year = {2026},
volume = {8},
number = {15},
pages = {4347--4361},
doi = {10.1039/d5na01168j}
}
EUVIMED